“borderline significant”

For NEUTs, a borderline significant decrease was observed between points II and III ( p = 0.05).

In exploring sources of heterogeneity using univariate meta regression, sex demonstrated a borderline significant effect (β = 0.27, P = 0.05), suggesting it may partially account for variation across studies.

The estimated yearly decrease in trachoma in the control communities was -·04%, compared with -0·9% in the intervention communities, and this difference in the rate of change between control and intervention communities was borderline significant (p = 0·05).

According to education level, a borderline significant difference was observed among the groups (F = 2.43, p = 0.050).

Notably, L491P showed a borderline significant increase post-ART (15.8% vs. 25.4%, p = 0.05). 3.5.

Cancers of the oral cavity and pharynx showed a borderline significant association in the unadjusted model (p = 0.05) but after adjustment for confounding the trend in relation to Ab levels was positive but not statistically significant (OR for medium Ab = 1.1, and high Ab = 1.5 p = 0.13).

evansi was higher than in the other breeding systems (borderline significant, p = 0.05).

A Friedman test shows a borderline significant difference in pressure pain thresholds between the groups ( p = 0.050).When groups are tested pairwise with a Wilcoxon Signed Rank Test, statistically significant differences can be found.

However, there was a borderline significant sex-difference (P = 0.05) in the association between EPA and AO; and EPA was associated with AO (P = 0.03), SAD (P = 0.03), and WC (P = 0.02) in women, when evaluated in sex-specific analyses using multivariable-adjusted models ( S2 and S3 Tables).

While the use of corticosteroids showed a borderline significant benefit (MD = 1.34, 95% CI: 0.01–2.67, p = 0.05), ALA supplementation did not significantly enhance olfactory recovery (MD = 0.50, 95% CI: −0.07–1.07, p = 0.08).

For MD, the correlation was borderline significant ( ρ = −0.154, p = 0.050 for MD; ρ = −0.095, p = 0.231 for FA).

The effect of loneliness on physical activity was borderline significant in the actively isolated group ( p = 0.050).

Moreover, in a prospective randomized, double-blind, placebo-controlled trial enrolling 106 patients with both NAFLD and T2DM who were assigned to receive empagliflozin 10 mg ( n = 35), pioglitazone 30 mg ( n = 34), or placebo ( n = 37) for 24 weeks, only a borderline significant decrease in CAP score was observed with empagliflozin compared with placebo (−29.6 dB/m (−39.5 to −19.6) vs. −16.4 dB/m (−25.0 to −7.8), respectively; p = 0.05) [ 39 ].

However, there was a borderline significant difference (p = 0.05) for pancreatic insufficiency: all patients included in the rapid group were pancreatic insufficient, while 15 of the 18 patients in the slow progression group were pancreatic insufficient.

There was a significant fibrosis‐adjusted treatment effect for TPIP vs placebo of 3.8% (P = 0.02) onBV5A‐PR and a borderline significant fibrosis‐adjusted treatment effect for TPIP vs placebo of 6.4% (P = 0.05) onBV5A‐PRA.

Next, we analysed the prognostic indices by multivariate Cox proportional hazard regression (1) by using either significant ( p < 0.05) or borderline significant ( p = 0.05–0.10) indices in the univariate analysis (first multivariate analysis) or (2) by using the selected features with random forest algorithms (second multivariate analysis).

This study found that patients with CeD, younger-onset diabetes, MS, asthma, and SLE were at higher risk of ALS, and the rate ratio for UC was borderline significant ( P = 0.05), and no significant difference was found for RA, psoriasis and CD.

A borderline significant correlation between IGFBP1 DNA methylation levels and IGFBP-1 serum levels was found in non-diabetic subjects ( r = 0.186, P = 0.050), but not in newly diagnosed type 2 diabetes patients ( P = 0.770) or patients undergoing treatment ( P = 0.230).

Body weight: There was a borderline significant difference in BW‐kg change between study arms ( P = 0.05).

A borderline significant difference was observed among subgroups ( p = 0.05) ( Figure 6 ). 3.4.3.

In the univariable survival analysis, patients using TNFi therapy had borderline significant lower discontinuation due to any reason (unadjusted HR=0.83 (95% CI 0.69 to 1.00, p=0.05)) compared with patients using TOFA therapy ( table 2 ).

Similar to the L6 diet, the H3-L6 diet also increased PGF2a concentration by 21% compared to baseline, but this increase was borderline significant ( p = 0.05).

On the contrary, there was a borderline significant difference between diabetic and healthy children in the category of good oral hygiene ( p = 0.05).

There was, however, a borderline significant difference ( P = .05) for higher daily sugar-sweetened beverage consumption for the PI group (32.3%) compared with the EI group (22.4%) ( Table 1 ).

The impact of heterogeneity in our meta-analysis was borderline significant ( P =0.05).